Suppr超能文献

谷胱甘肽S-转移酶M1、细胞色素P450 1A1和细胞色素P450 2E1基因多态性与肺腺癌易感性的关联:一项中国人群病例对照研究

Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population.

作者信息

Wang Jingwen, Deng Yifu, Li Li, Kuriki Kiyonori, Ding Jianmin, Pan Xiaochun, Zhuge Xin, Jiang Jing, Luo Chenhong, Lin Peng, Tokudome Shinkan

机构信息

Department of Health Promotion and Preventive Medicine, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya 467-8601, Japan.

出版信息

Cancer Sci. 2003 May;94(5):448-52. doi: 10.1111/j.1349-7006.2003.tb01463.x.

Abstract

A case-control study of 164 lung adenocarcinoma (AC) patients with 181 age- and gender-matched healthy controls was conducted in order to assess any associations between glutathione-S-transferase M1 (GSTM1), cytochrome P4501A1 (CYP1A1) and cytochrome P4502E1 (CYP2E1) polymorphisms and susceptibility to lung AC in Chinese. The presence of CYP2E1 variant allele was significantly less frequent in cases than in controls, while the distribution of GSTM1 null genotype and variant CYP1A1 Msp1 allele did not vary between cases and controls. After adjustment for age, gender, smoking and all other genotypes, the CYP2E1 Rsa1 variant allele was significantly associated with decreased risk of lung AC [odds ratio 0.534 (95% confidence interval, 0.340-0.837)]. Furthermore, 3.0-fold increased risk was found in individuals with combined GSTM1 null genotype and CYP2E1 Rsa1 wild type versus those with combined GSTM1 non-null type and CYP2E1 variant allele. Our results suggest that CYP2E1 Rsa1 variant allele is associated with a decreased risk of lung AC, and combined GSTM1 null genotype and CYP2E1 Rsa1 wild type has a promoting effect on susceptibility to lung AC.

摘要

为了评估谷胱甘肽 - S - 转移酶M1(GSTM1)、细胞色素P4501A1(CYP1A1)和细胞色素P4502E1(CYP2E1)基因多态性与中国人群肺腺癌(AC)易感性之间的关联,开展了一项病例对照研究,该研究纳入了164例肺腺癌患者以及181例年龄和性别匹配的健康对照。病例组中CYP2E1变异等位基因的出现频率显著低于对照组,而GSTM1无效基因型和CYP1A1 Msp1变异等位基因在病例组和对照组之间的分布没有差异。在对年龄、性别、吸烟及所有其他基因型进行校正后,CYP2E1 Rsa1变异等位基因与肺腺癌风险降低显著相关[比值比0.534(95%置信区间,0.340 - 0.837)]。此外,与GSTM1非无效型和CYP2E1变异等位基因组合的个体相比,GSTM1无效基因型和CYP2E1 Rsa1野生型组合的个体患癌风险增加了3.0倍。我们的结果表明,CYP2E1 Rsa1变异等位基因与肺腺癌风险降低有关,而GSTM1无效基因型和CYP2E1 Rsa1野生型组合对肺腺癌易感性有促进作用。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验